Non-Small Cell Lung Cancer

New non-small cell lung cancer study findings reported from University Medical Center

Published in Cancer Weekly, February 2nd, 2010

"Improved local tumor control (LC) improves survival of patients with non-small cell lung cancel (NSCLC)," scientists in Netherlands report.

"We estimated the capability of surgical and non-surgical options to improve LC further in this disease," wrote D. Deruysscher and colleagues, University Medical Center.

The researchers concluded: "Eligible studies were phase III trials reporting 2-year survival data as well as the incidence of LC and/or distant metastases Effect estimates. as well as the statistical uncertainty of these, were combined in circlet to estimate the benefit in terms of LC from combining multiple modalities Results It was estimated...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2010-02-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry